Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiuling Zhi

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Frontiers in Immunology|March 9, 2026
Neoadjuvant chemotherapy-induced immune remodeling in ovarian cancer: implications for TIL dynamics and combination immunotherapyWanting Zhu, Jiajia Li, Yihua Sun, et al.
Journal of Cellular Physiology|November 13, 2018
Ecto-5'-nucleotidase (CD73) is a potential target of hepatocellular carcinomaShalaimaiti Shali, Jiangang Yu, Xin Zhang, et al.
American Journal of Cancer Research|May 6, 2020
CDK9 inhibitor CDKI-73 is synergetic lethal with PARP inhibitor olaparib in BRCA1 wide-type ovarian cancerJiajia Li, Xiuling Zhi, Shuyi Chen, et al.
Clinical & Experimental Metastasis|March 20, 2013
Ecto-5'-nucleotidase (CD73) promotes tumor angiogenesisLi Wang, Shaoxian Tang, Yingjian Wang, et al.
Journal of Cancer Research and Clinical Oncology|August 3, 2007
Ecto-5'-nucleotidase promotes invasion, migration and adhesion of human breast cancer cellsLi Wang, Xuerui Zhou, Tingting Zhou, et al.
European Journal of Pharmacology|August 6, 2021
SPTBN1 inhibits growth and epithelial-mesenchymal transition in breast cancer by downregulating miR-21Huijie Wu, Shuyi Chen, Chenyang Liu, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 28, 2017
Resveratrol inhibits Extranodal NK/T cell lymphoma through activation of DNA damage response pathwayXianxian Sui, Canjing Zhang, Jianan Zhou, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 31, 2025
The Multifaceted Roles of BACH1 in Disease: Implications for Biological Functions and Therapeutic ApplicationsXiangxiang Wei, Yunquan He, Yueyang Yu, et al.
Cancer Letters|January 18, 2019
BTB and CNC homology 1 (Bach1) promotes human ovarian cancer cell metastasis by HMGA2-mediated epithelial-mesenchymal transitionWenyan Han, Yiqun Zhang, Cong Niu, et al.
Journal of Cellular Physiology|November 3, 2023
Tumor cell SPTBN1 inhibits M2 polarization of macrophages by suppressing CXCL1 expressionHuijie Wu, Nan Jiang, Jiajia Li, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|March 9, 2026
Neoadjuvant chemotherapy-induced immune remodeling in ovarian cancer: implications for TIL dynamics and combination immunotherapyWanting Zhu, Jiajia Li, Yihua Sun, et al.
Journal of Cellular Physiology|November 13, 2018
Ecto-5'-nucleotidase (CD73) is a potential target of hepatocellular carcinomaShalaimaiti Shali, Jiangang Yu, Xin Zhang, et al.
American Journal of Cancer Research|May 6, 2020
CDK9 inhibitor CDKI-73 is synergetic lethal with PARP inhibitor olaparib in BRCA1 wide-type ovarian cancerJiajia Li, Xiuling Zhi, Shuyi Chen, et al.
Clinical & Experimental Metastasis|March 20, 2013
Ecto-5'-nucleotidase (CD73) promotes tumor angiogenesisLi Wang, Shaoxian Tang, Yingjian Wang, et al.
Journal of Cancer Research and Clinical Oncology|August 3, 2007
Ecto-5'-nucleotidase promotes invasion, migration and adhesion of human breast cancer cellsLi Wang, Xuerui Zhou, Tingting Zhou, et al.
European Journal of Pharmacology|August 6, 2021
SPTBN1 inhibits growth and epithelial-mesenchymal transition in breast cancer by downregulating miR-21Huijie Wu, Shuyi Chen, Chenyang Liu, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 28, 2017
Resveratrol inhibits Extranodal NK/T cell lymphoma through activation of DNA damage response pathwayXianxian Sui, Canjing Zhang, Jianan Zhou, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 31, 2025
The Multifaceted Roles of BACH1 in Disease: Implications for Biological Functions and Therapeutic ApplicationsXiangxiang Wei, Yunquan He, Yueyang Yu, et al.
Cancer Letters|January 18, 2019
BTB and CNC homology 1 (Bach1) promotes human ovarian cancer cell metastasis by HMGA2-mediated epithelial-mesenchymal transitionWenyan Han, Yiqun Zhang, Cong Niu, et al.
Journal of Cellular Physiology|November 3, 2023
Tumor cell SPTBN1 inhibits M2 polarization of macrophages by suppressing CXCL1 expressionHuijie Wu, Nan Jiang, Jiajia Li, et al.
Pageof 7